Yarbrough Capital, LLC Seagen Inc. Transaction History

Yarbrough Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	SELL	$191.51 - $216.16 $462,879 - $522,458	-2,417 Reduced 53.4%	2,109 $447,000
Q1 2023 Apr 13, 2023	BUY	$127.59 - $203.08 $269,087 - $428,295	2,109 Added 87.26%	4,526 $916,000
Q2 2022 Jul 08, 2022	SELL	$108.81 - $179.33 $54,731 - $90,202	-503 Reduced 17.23%	2,417 $428,000
Q1 2022 Apr 14, 2022	BUY	$119.61 - $157.85 $60,163 - $79,398	503 Added 20.81%	2,920 $421,000
Q4 2021 Feb 01, 2022	BUY	$142.57 - $190.86 $344,591 - $461,308	2,417 New	2,417 $374,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Yarbrough Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Yarbrough Capital, LLC with notifications on news.